BNET Industries
Market Cap:$444.0M
Last Fiscal Year Sales:$13.3M
- Public
- US
Dow Jones Description
Insulet Corporation is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use parts with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of continuous subcutaneous insulin infusion (CSII) therapy among people with insulin-dependent diabetes. Founded in 2000, Insulet is based in Bedford, MA.
Board of Directors
Alison de BordNumber of Employees 247
Peer Companies
NAICS Code Surgical and Medical Instrument Manufacturing: 339112
Recent Events
-
Unusual 11 Mid-Day Movers 10/27: HPGP, CTDC, HLND, UCTT Higher; AMFI, CRI, SGMS, IBCP Lower
-
BUYINS.NET: EXTR, NBTB, PODD, WAL Expected To Be Higher After Earnings Releases on Monday
-
CORRECTED - CORRECTED-(OCT 26) UPDATE 1-Insulet posts wider Q3 loss, ups '09
-
BUYINS.NET: 49.89% Of All NASDAQ Trading Monday Was Short Selling. SPLS, MASI, PVTB, INFA, PODD,...
-
Soleil Starts Insulet PODD at Buy, DexCom DXCM at Hold
-
Insulet Corp. appoints new chief commerical officer
-
Human Capital: People on the Move, Aug. 18
-
Insulet Reports Second Quarter 2009 Results
News & Analysis
Filter by
insulet corp. - All News and Analysis
Insulet Corporation Q2 2009 Earnings Call Transcript
Question-and-Answer SessionOperator Operator Instructions And your first question comes from line of Ben Andrew with William Blair, you may proceed. Ben Andrew – William Blair Good afternoon guys, just a couple of quick questions if I may. First; the Cosmo patients that have been up for grabs, how big...
Insulet Corporation Q2 2009 Earnings Call Transcript
Insulet Corp. PODD Q2 2009 Earnings Call August 04, 2009; 5:00 pm ET
Insulet Corporation Not Yet an Attractive Short Opportunity
Reggie Middleton submits: We performed some preliminary analysis on Insulet Corporation PODD with a focus on its latest quarterly results. With its stock price currently trading in the region of US$7-$8 per share, it fails in the very first parameter that we use for screening short candidates, and that is...
Insulet Corporation Q3 2008 Earnings Call Transcript
Question-and-Answer SessionOperator Operator instructions And the first question comes from the line of Mike Weinstein with JP Morgan. Please proceed. Mike Weinstein – JP Morgan Thank you. Good evening. Just a couple questions to start with. First, what's the – Carsten, what's the gross margin on the...
Insulet Corporation, Q2 2008 Earnings Call Transcript
Question-and-Answer SessionOperator Operator Instructions And your first question comes from the line of Michael Weinstein with JPMorgan. Please proceed. Kim - J.P.Morgan Hi guys, it is Kim here for Mike. Can you hear me? Duane DeSisto Yes Kim. Kim - J.P.Morgan Great. It sounds like we have got a...
Insulet Corporation Q1 2008 Earnings Call Transcript
Question-and-Answer SessionOperator Operator Instructions Your first question comes from Paul K. Choi - Merrill Lynch. Paul K. Choi - Merrill Lynch First on the patient adds you have in the past couple quarters added about 1,100, 1,200 patients each quarter here while you’ve been wrapping...
Insulet Corporation Q4 2007 Earnings Call Transcript
Question-and-Answer Session Operator Operator Instructions Your first question comes from the line of Michael Weinstein with JP Morgan. Please proceed. Analyst for Michael Weinstein – JP Morgan Just a couple, I wanted to see if you could talk a little bit more in detail on your marketing...
Insulet Corporation Announces Pricing of IPO.
M2 PRESSWIRE-15 May 2007-ExplorationInvestor: Insulet Corporation Announces Pricing of IPOC1994-2007 M2 COMMUNICATIONS LTD RDATE:15052007 Exploration Investor strives to provide you with outstanding market results. We will be your number one resource for all your small and large cap needs. While working...
Funding to Help Beverly, Mass., Firm to Help Develop Disposable Insulin Pump.
By Jeffrey Krasner, The Boston Globe Knight Ridder/Tribune Business News Aug. 8--Insulet Corp. of Beverly is expected to announce today that it has won $11 million in venture capital funding from groups including Versant Ventures, Schoder Ventures Life Sciences and Prism Venture ...
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Charles Warden | Director |
| Chris Kaster | Director |
| Jonathan Silverstein | Director |
| Juliet Bakker | Director |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Alison de Bord | Board of Directors |
| Derek Lee | Board Observer |
| Gordie Nye | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| Omnipod Insulin Management System | Board of Directors | Current |
| Prolacta Bioscience | Board Member | Current |
| Aegerion Pharmaceuticals Inc | Board of Directors | Current |
| Insulet Corp | Board of Directors | Current |
| Surgrx, Inc | Board of Directors | Current |
| Geron Corporation | Associate | Former |
| Robertson, Stephens & Company | Senior Associate | Former |
| Columbia University | M.B.A. | Former |
| Columbia Business School | Master of Business Administration | Former |
| Colgate University | Bachelor of Arts In History | Former |
Charles Warden has focused on investing in medical devices since entering the venture capital business in 1992. Before joining Versant he was a general partner with Schroder Ventures Life Sciences. In that capacity, he also focused on medical device company investments and was instrumental in building and leading the medical device effort for the firm. Previously, Charles worked with Boston Capital Ventures, where he concentrated on medical device and other healthcare investments, prior to which he was a consultant with Monitor Company, a strategy consulting firm. Charles has served on numerous medical device company boards, including the following of which he is presently a member: AcuFocus, Celula, Concentric Medical, Glumetrics, LipoSonix and WaveTec. In addition, since its inception, Charles has been actively involved with The Innovation Factory, a medical devices incubator. Charles holds a Bachelor's degree from Beloit College and an MBA from Harvard Business School.
| Organization | Position | Status |
|---|---|---|
| Versant Ventures | Managing Director | Current |
| Insulet Corp | Director | Current |
| Acufocus | Director | Current |
| Confluent Surgical, Inc. | Board of Directors | Current |
| Liposonix, Inc | Director | Current |
| Concentric Medical, Inc. | Director | Current |
| Cardiofocus, Inc. | Director | Current |
| Sadra Medical | Director | Current |
| The Innovation Factory, LLC | Board of Directors | Current |
| Monitor Group | consultant | Former |
| The Monitor | Consultant | Former |
| Boston Capital Ventures | Former | |
| Versant Corporation | Former | |
| Harvard Business School | Mba | Former |
| Beloit College | Bachelor's Degree | Former |
| Organization | Position | Status |
|---|---|---|
| Medventure Associates | Partner | Current |
| Insulet Corp | Director | Current |
| Aesthera Corp. | Board of Directors | Current |
| Game Ready Equine | Member, Board of Directors | Current |
| PolyRemedy, Inc | Board of Directors | Current |
| Sara-Tech | Board of Directors | Current |
| CoolSystems Inc. | Member, Board of Directors | Current |
| Medventure Associates | Member | Current |
| Inamed Corporation | Investment Analysis | Former |
| Piper Jaffray Companies | Equity Research Analyst | Former |
| General Mills, Inc. | Sales and Marketing | Former |
| TheraSense, Inc. | Investment Analysis | Former |
| Kyphon, Inc. | Investment Analysis | Former |
| WR Hambrecht & Co. LLC | Senior Equity Research Analyst | Former |
| University of Minnesota | M.B.A | Former |
| St. Olaf College | B.A | Former |
| Organization | Position | Status |
|---|---|---|
| Quick Study Radiology, Inc | Observer | Current |
| Aderis Pharmaceuticals, Inc. | Observer | Current |
| Achillion Pharmaceuticals, Inc | Observer | Current |
| Sv Life Sciences Advisers Llp | Principal | Current |
| Micromed Technology, Inc. | Observer | Current |
| Achillion Pharmaceuticals, Inc | Board Observer | Current |
| Auxilium Pharmaceuticals, Inc. | Board Observer | Current |
| Insulet Corp | Board Observer | Current |
| Aderis Pharmaceuticals, Inc. | Board Observer | Current |
| Micromed Technology, Inc. | Board Observer | Current |
| UBS Warburg | Associate | Former |
| Global Healthcare Group LLC | Associate | Former |
| Bentley College | BS in Finance | Former |
| Organization | Position | Status |
|---|---|---|
| Prism Venture Partners | General Partner | Current |
| Professional Resources & Information Systems Management Inc | Current | |
| Confirma, Inc. | Board of Directors | Current |
| Aptus Endosystems Inc. | Board of Directors | Current |
| Medmanage Systems, Inc. | Board Member | Current |
| Atritech, Inc. | Board of Directors | Current |
| Coaxia, Inc. | Board of Directors | Current |
| Insulet Corp | Board of Directors | Current |
| Alta Partners | Board of Directors | Current |
| Omnipod Insulin Management System | Board of Directors | Current |
| Myocor, Inc. | Board of Directors | Current |
| A Company, Inc. | CEO | Former |
| A Company, Inc. | President | Former |
| Dartmouth College | Master of Business Administration | Former |
| Dartmouth College | Bachelor of Arts | Former |
| Organization | Position | Status |
|---|---|---|
| Orbimed Advisors, LLC | General Partner | Current |
| NxStage Medical, Inc. | Director of Nxstage | Current |
| Enobia Pharma Inc | Chairman of the Board | Current |
| Gelesis Inc. | Chairman | Current |
| Emphasys Medical, Inc | Board of Directors | Current |
| Omnipod Insulin Management System | Board of Directors | Current |
| Adiana | Board of Directors | Current |
| Cerapedics | Director | Current |
| Gelesis Inc. | Board of Directors | Current |
| Predix Pharmaceuticals Holdings, Inc. | Board of Directors | Current |
| Given Imaging Ltd. | Board of Directors | Current |
| Alta Partners | Board of Directors | Current |
| NxStage Medical, Inc. | Board of Directors | Current |
| Medtech Investing Conference | Board of Directors | Current |
| Insulet Corp | Director | Current |
| AVANIR Pharmaceuticals | Director | Current |
| Mentor Corporation | Manager | Former |
| TransVascular, Inc. | Manager | Former |
| Life Sciences, Inc. | Director | Former |
| LifeCell Corporation | Director | Former |
| Orthovita, Inc. | Director | Former |
| University of San Diego | J.D. | Former |
| Denison University | J.D. | Former |
| University of San Diego School of Law | J.D. | Former |
| University of San Diego | M.B.A. | Former |
| Denison University | B.A. In Economics | Former |
| Organization | Position | Status |
|---|---|---|
| Pequot Capital Management Inc. | Managing Director | Current |
| Longitude Capital Management Co., LLC. | Managing Director | Current |
| Disc Dynamics, Inc. | Board of Directors | Current |
| Ablation Frontiers Inc. | Board of Directors | Current |
| Aptus Endosystems Inc. | Board of Directors | Current |
| The Livingston Ripley Waterfowl Sanctuary | Board of Directors | Current |
| Altiva Corporation | Board of Directors | Current |
| Acufocus | Board of Directors | Current |
| Sanarus Medical, Inc. | Director | Current |
| Sadra Medical | Board Member | Current |
| The National Audubon Society, Inc | Board of Directors | Current |
| Insulet Corp | Director | Current |
| Facet Solutions, Inc. | Board Member | Current |
| Pequot Ventures | Managing Director | Former |
| Longitude Capital Management Co., LLC. | Founder | Former |
| PaineWebber, Inc. | Investment Banker | Former |
| BNP Paribas SA | Equity Research Analyst | Former |
| Cornell University | B.S. in Biological Sciences | Former |
Industry Transcripts by Seeking Alpha
-
Medtronic Inc. F2Q10 (Qtr End 10/30/09) Earnings Call Transcript
on Nov 24, 2009about MDT
-
ZOLL Medical Corporation F4Q09 (Qtr End 27/09/09) Earnings Call Transcript
on Nov 11, 2009about ZOLL
-
RadNet, Inc. Q3 2009 Earnings Call Transcript
on Nov 09, 2009about RDNT
-
Cytori Therapeutics Q3 2009 Earnings Call Transcript
on Nov 09, 2009about CYTX
-
StoneMor Partners L.P. 3Q09 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 09, 2009about STON
IndustryTop Rated
- Why So Many Insured People Have Big Medical Debts 5 votes
- Physicians Know We Need Reform 4 votes
- Hospital Chain's Turnaround Raises Health Spending 3 votes
- Healthcare Is Still Adding Jobs, Despite Recession 3 votes
- Healthcare Roundup: Medical Office Space in Demand, Blues Companies See Lower Income, Two Sides of Health Insurance, and More 3 votes


